February 19, 2025
February 19, 2025
Late-Window Alteplase in Acute Ischemic Stroke
February 19, 2025
FDA Approves Amneal’s Lenalidomide; Mesalamine 800 mg Launched
February 19, 2025
New Technique Could Improve Veneer Fit, Quality
February 19, 2025
Higher Calcium Intake Cuts Colorectal Cancer: Study
February 19, 2025
Recurrent Hyperpigmented Patches After GLP-1 Therapy: What's Your Diagnosis?
Latest Headlines
View More
February 20, 2025
A Precision Medicine Revolution
February 19, 2025
Oral Disease Spending Tops Ischemic Heart Disease
February 19, 2025
Late-Window Alteplase in Acute Ischemic Stroke
February 19, 2025
FDA Approves Amneal’s Lenalidomide; Mesalamine 800 mg Launched
February 19, 2025
Untreated CLL: Acalabrutinib Combinations vs Chemoimmunotherapy
Daily News
Stay up to date with the latest clinical headlines and other information tailored to your specialty.
Trending Now
1
Immunosuppressive Therapy Withdrawal and Renal Relapse Risks
2
Medical Oddities: Sex, Lies, and Bacteria
3
FDA Clears Aptima SARS-CoV-2 Assay for High-Throughput Testing
4
New Study Shows Promise in Enhanced Stroke Treatment Protocol
5
CDC Cuts 1,300 Workers Amid Overhaul
6
Routine Flossing May Lower Stroke Risk
Conference Coverage
American Stroke Association International Stroke Conference 2025
February 19, 2025
Late-Window Alteplase in Acute Ischemic Stroke
February 18, 2025
Telomere Length May Signal Brain Disease Risk
February 18, 2025
New Study Shows Promise in Enhanced Stroke Treatment Protocol
2025 ASCO GU
2025 ASCO GI
Clinical Guidelines
View More
February 18, 2025
AAP Guide Targets Early Biliary Atresia
Commentary & Perspectives
View More
February 18, 2025
New Study Shows Promise in Enhanced Stroke Treatment Protocol
February 18, 2025
Fraudulent Pain Injections Tied to Opioid Access
February 12, 2025
Free Clinic, Small Town—Worth the Move?
February 12, 2025
Free Clinic, Small Town—Worth the Move?
FDA & Government News
View More
February 19, 2025
FDA Approves Amneal’s Lenalidomide; Mesalamine 800 mg Launched
February 19, 2025
FDA Clears Novel Atopic Dermatitis Drug
February 18, 2025
FDA Clears Aptima SARS-CoV-2 Assay for High-Throughput Testing
February 18, 2025
FDA Qualifies Two-Level RDL for AUD Trials
Business Management
View More
February 19, 2025
Product: New Chairside 3D Printing Solution
February 14, 2025
Study: Patients Trust Female Docs Less
February 14, 2025